1. Stocks
    2. /
  2. Imugene Limited (ASX: IMU)
    3. /

Imugene Limited (ASX: IMU) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Imugene Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Imugene Limited (ASX: IMU)
    Latest News

    Shot of a scientist using a computer while conducting research in a laboratory.
    Healthcare Shares

    2 All Ords ASX healthcare shares making BIG moves on quarterly updates

    | Bernd Struben

    These two ASX healthcare companies are seeing heavy trading on Thursday.

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why AGL, Imugene, Star, and Woolworths shares are dropping today

    | James Mickleboro

    These shares are dropping on Thursday. Let's see why investors are selling them.

    Read more »

    Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
    Share Gainers

    Why Appen, Cettire, DroneShield, and Imugene shares are racing higher

    | James Mickleboro

    These shares are starting the week in style. But why?

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Why this ASX All Ords stock is soaring 30% on Monday

    | James Mickleboro

    This stock is starting the week with a bang. But why?

    Read more »

    A man wearing glasses and a white t-shirt pumps his fists in the air looking excited and happy about the rising OBX share price
    Share Gainers

    Why Catalyst Metals, Imugene, Red 5, and Telstra shares are pushing higher today

    | James Mickleboro

    These shares are outperforming on Wednesday. But why?

    Read more »

    A women cheers with clenched fists having read some good news on her laptop.
    Share Gainers

    2 ASX shares roaring higher on big news

    | James Mickleboro

    Investors are pleased with these announcements. Let's find out why.

    Read more »

    Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
    Healthcare Shares

    3 ASX healthcare shares outperforming on quarterly updates

    | Bronwyn Allen

    These stocks are charging ahead on an otherwise lacklustre trading day.

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Healthcare Shares

    Broker says this ASX biotech stock could almost double in value

    | James Mickleboro

    Bell Potter is feeling very bullish about this risky stock.

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Imugene, Liontown, Pointsbet, and Regis Resources shares are storming higher

    | James Mickleboro

    These ASX shares are having a great session. But why?

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Guess which ASX 300 healthcare stock is storming higher on Chinese patent news

    | James Mickleboro

    Here's why this healthcare share is catching the eye on Thursday.

    Read more »

    Shot of a young scientist using a digital tablet while working in a lab.
    Healthcare Shares

    This ASX All Ords healthcare share is leaping 10% on cancer-killing drug trial progress

    | Bronwyn Allen

    Investors are excited over some further news released by the company today.

    Read more »

    Arrows pointing upwards with a man pointing his finger at one.
    Share Gainers

    Why Data#3, Deep Yellow, DroneShield, and Imugene shares are racing higher today

    | James Mickleboro

    These ASX shares are catching the eye on Wednesday. But why?

    Read more »

    Frequently Asked Questions

    Imugene does not pay dividends at this stage. 

    Imugene Ltd (ASX: IMU) listed on the ASX on 24 November 1993.

    IMU ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Imugene Limited

    Imugene Ltd (ASX: IMU) is a biotechnology company working in cancer immunotherapy.

    The company specialises in clinical-stage immuno-oncology therapies. Its product pipeline includes Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard-care drugs and immunotherapies.

    The company's lead product is HER-Vaxx, a proprietary cancer vaccine for the treatment of gastric and breast cancer, where the cancer is HER-2 positive. The vaccine has demonstrated it stimulates a polyclonal antibody response to HER2/neu. 

    Imugene's various immunotherapy products are involved in ongoing clinical trials involving cancer specialists and researchers worldwide.

    Profile

    since

    Note